Advanced Search
Korean J Pediatr 2017 July;60(7) :227-231.
Published online 2017 July 15.        doi:
Effects of low-dose topiramate on language function in children with migraine
Seung-A Han1, Eu Jeen Yang2, Younghwa Kong1, Chan-Uhng Joo1,3, Sun Jun Kim1,3
1Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea
1,3Research Institute of Clinical Medicine, Chonbuk National University Medical School, Jeonju, Korea
2Department of Pediatrics, Pusan National University Childrens Hospital, Yangsan, Korea
Corresponding Author: Sun Jun Kim ,Tel: +82-63-250-1799, Fax: +82-63-250-1464, Email:
Copyright © 2017 by The Korean Pediatric Society
Purpose: This study aimed to verify the safety of low-dose topiramate on language development in pediatric patients with migraine.
Methods: Thirty newly diagnosed pediatric patients with migraine who needed topiramate were enrolled and assessed twice with standard language tests, including the Test of Language Problem Solving Abilities (TOPs), Receptive and Expressive Vocabulary Test, Urimal Test of Articulation and Phonology, and computerized speech laboratory analysis. Data were collected before treatment, and topiramate as monotherapy was sustained for at least 3 months. The mean follow-up period was 4.3 2.7 months. The mean topiramate dosage was 0.9 mg/kg/day.
Results: The patients mean age was 144.142.3 months (male-to-female ratio, 9:21). The values of all the language parameters of the TOPs were not changed significantly after the topiramate treatment as follows: Determine cause, from 15.04.4 to 15.44.8 (P>0.05); making inference, from 17.65.6 to 17.56.6 (P>0.05); predicting, from 11.54.5 to 12.34.0 (P>0.05); and total TOPs score, from 44.1 13.4 to 45.313.6 (P>0.05). The total mean length of utterance in words during the test decreased from 44.113.4 to 45.313.6 (P<0.05). The Receptive and Expressive Vocabulary Test results decreased from 97.722.1 to 96.319.9 months, and from 81.823.4 to 82.325.4 months, respectively (P>0.05). In the articulation and phonology validation in both groups, speech pitch and energy were not significant, and all the vowel test results showed no other significant values.
Conclusion: No significant difference was found in the language-speaking ability between the patients; however, the number of vocabularies used decreased. Therefore, topiramate should be used cautiously for children with migraine.
Keywords: Child | Migraine | Prophylactic agents | Language | Topiramate
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy  2017 December;60(12)
Usefulness of neutrophil-lymphocyte ratio in young children with febrile urinary tract infection  2016 March;59(3)
Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy  2014 April;57(4)
Effect of adenotonsillar hypertrophy on right ventricle function in children  2014 November;57(11)
Characteristics of late-onset epilepsy and EEG findings in children with autism spectrum disorders  2011 January;54(1)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact:
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail:
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.